ID

12880

Descrizione

Documentation part: Table II [Recommendations for core asthma outcomes for NIH- initiated clinical research for adults and adolescents (>= 12 years of age)]. ODM derived from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259286/ Background: Asthma clinical research will highly benefit from standardization of major outcomes in terms of definition and assessment methodology. This will permit useful comparisons across interventional or observational studies and will allow more effective data sharing. Objective: National Institutes of Health (NIH) institutes and the Agency for Healthcare Research and Quality (AHRQ) convened a workshop involving 7 expert subcommittees to propose which asthma outcomes should be assessed with standardized methodology in future asthma clinical research studies. Permission granted by: Michelle Freemer.

collegamento

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259286/

Keywords

versioni (2)
  1. 05/01/2016 05/01/2016 -
  2. 23/02/2016 23/02/2016 -
Caricato su

5 de janeiro de 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Table II- Core Asthma Outcomes NIH AHRQ for adults and adolescents >= 12 years of age

Inglese

Table II- Core Asthma Outcomes NIH AHRQ for adults and adolescents >= 12 years of age

1 moduli  
Characterization of study population for prospective clinical trials
Descrizione

Characterization of study population for prospective clinical trials

Alias
UMLS CUI-1
C2348561
UMLS CUI-2
C1880022
UMLS CUI-4
C0008976
Serologic multi­allergen screen (IgE) to define atopic status (also for observational studies)
Descrizione

Biomarkers Serologic

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0005516
UMLS CUI [1,2]
C0205473
Either ACQ or ACT
Descrizione

ACQ (Asthma Control Questionnaire) ACT (Asthma Control Test)

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0449820
UMLS CUI [1,2]
C0205199
Events in the 12 months prior to study entry:
Descrizione

Exacerbation of asthma

Tipo di dati

text

Alias
UMLS CUI [1]
C0349790
History of:
Descrizione

Utilization healthcare; Costs healthcare

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0042153
UMLS CUI [1,2]
C0086388
UMLS CUI [2,1]
C0010186
UMLS CUI [2,2]
C0086388
Spirometry (pre­ and post­ bronchodilator)
Descrizione

Physiology Pulmonary

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0031842
UMLS CUI [1,2]
C0024109
Prospective clinical trial efficacy/ effectiveness outcomes
Descrizione

Prospective clinical trial efficacy/ effectiveness outcomes

Alias
UMLS CUI-1
C0008976
UMLS CUI-2
C1280519
Either ACQ or ACT
Descrizione

ACQ (Asthma Control Questionnaire) ACT (Asthma Control Test)

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0449820
UMLS CUI [1,2]
C0205199
Events in the 12 months prior to study entry:
Descrizione

Exacerbation of asthma

Tipo di dati

text

Alias
UMLS CUI [1]
C0349790
History of:
Descrizione

Utilization healthcare; Costs healthcare

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0042153
UMLS CUI [1,2]
C0086388
UMLS CUI [2,1]
C0010186
UMLS CUI [2,2]
C0086388
If option 4 chosen above, please mention the name, dose and duration of the asthma medication used
Descrizione

medication asthma

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0004096
Spirometry (without bronchodilator)
Descrizione

Physiology Pulmonary

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0031842
UMLS CUI [1,2]
C0024109
Observational study outcomes
Descrizione

Observational study outcomes

Alias
UMLS CUI-1
C1518527
UMLS CUI-2
C0086749
Either ACQ or ACT
Descrizione

ACQ (Asthma Control Questionnaire) ACT (Asthma Control Test)

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0449820
UMLS CUI [1,2]
C0205199
Events in the 12 months prior to study entry:
Descrizione

Exacerbation of asthma

Tipo di dati

text

Alias
UMLS CUI [1]
C0349790
History of:
Descrizione

Utilization healthcare; Costs healthcare

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0042153
UMLS CUI [1,2]
C0086388
UMLS CUI [2,1]
C0010186
UMLS CUI [2,2]
C0086388
If option 4 chosen above, please mention the name, dose and duration of the asthma medication used
Descrizione

medication asthma

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0004096
Spirometry (pre­ and post­ bronchodilator)
Descrizione

Physiology Pulmonary

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0031842
UMLS CUI [1,2]
C0024109
Ritorna all'inizio della pagina

Similar models

Table II- Core Asthma Outcomes NIH AHRQ for adults and adolescents >= 12 years of age

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Characterization of study population for prospective clinical trials
C2348561 (UMLS CUI-1)
C1880022 (UMLS CUI-2)
C0008976 (UMLS CUI-4)
Biomarkers Serologic
Item
Serologic multi­allergen screen (IgE) to define atopic status (also for observational studies)
text
C0005516 (UMLS CUI [1,1])
C0205473 (UMLS CUI [1,2])
Item
Either ACQ or ACT
text
C0449820 (UMLS CUI [1,1])
C0205199 (UMLS CUI [1,2])
Composite Scores
Code List
Either ACQ or ACT
CL Item
ACQ  (1)
CL Item
ACT (2)
Item
Events in the 12 months prior to study entry:
text
C0349790 (UMLS CUI [1])
Exacerbation of asthma
Code List
Events in the 12 months prior to study entry:
CL Item
Systemic corticosteroids for asthma (1)
CL Item
Asthma­-specific hospital admissions (2)
CL Item
Asthma­-specific ED visits (separate UC visits when these can be differentiated) (3)
Item
History of:
text
C0042153 (UMLS CUI [1,1])
C0086388 (UMLS CUI [1,2])
C0010186 (UMLS CUI [2,1])
C0086388 (UMLS CUI [2,2])
Utilization healthcare; Costs healthcare
Code List
History of:
CL Item
Asthma-­specific hospital admissions (1)
CL Item
Asthma­-specific ED visits (2)
CL Item
Asthma-­specific outpatient visits (3)
CL Item
Asthma-­specific medication use (4)
Physiology Pulmonary
Item
Spirometry (pre­ and post­ bronchodilator)
text
C0031842 (UMLS CUI [1,1])
C0024109 (UMLS CUI [1,2])
Item Group
Prospective clinical trial efficacy/ effectiveness outcomes
C0008976 (UMLS CUI-1)
C1280519 (UMLS CUI-2)
Item
Either ACQ or ACT
text
C0449820 (UMLS CUI [1,1])
C0205199 (UMLS CUI [1,2])
Composite Scores
Code List
Either ACQ or ACT
CL Item
ACQ  (1)
CL Item
ACT (2)
Item
Events in the 12 months prior to study entry:
text
C0349790 (UMLS CUI [1])
Exacerbation of asthma
Code List
Events in the 12 months prior to study entry:
CL Item
Systemic corticosteroids for asthma, for at least 3 days (1)
CL Item
Asthma-­specific hospital admissions (2)
CL Item
 Asthma-­specific ED visits (separate UC visits when these can be differentiated) (3)
CL Item
Asthma-­specific ICU admissions/intubations (4)
CL Item
 Death (all cause and asthma related) (5)
Item
History of:
text
C0042153 (UMLS CUI [1,1])
C0086388 (UMLS CUI [1,2])
C0010186 (UMLS CUI [2,1])
C0086388 (UMLS CUI [2,2])
Utilization healthcare; Costs healthcare
Code List
History of:
CL Item
Asthma-­specific hospital admissions  (1)
CL Item
Asthma­-specific ED visits  (2)
CL Item
Asthma-­specific outpatient visits  (3)
CL Item
Asthma-­specific detailed medication use (name, dose, duration) (4)
CL Item
Resource use related to the intervention (eg, personnel time, mite eradication, equipment) (5)
medication asthma
Item
If option 4 chosen above, please mention the name, dose and duration of the asthma medication used
text
C0013227 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
Physiology Pulmonary
Item
Spirometry (without bronchodilator)
text
C0031842 (UMLS CUI [1,1])
C0024109 (UMLS CUI [1,2])
Item Group
Observational study outcomes
C1518527 (UMLS CUI-1)
C0086749 (UMLS CUI-2)
Item
Either ACQ or ACT
text
C0449820 (UMLS CUI [1,1])
C0205199 (UMLS CUI [1,2])
Composite Scores
Code List
Either ACQ or ACT
CL Item
ACQ  (1)
CL Item
ACT (2)
Item
Events in the 12 months prior to study entry:
text
C0349790 (UMLS CUI [1])
Exacerbation of asthma
Code List
Events in the 12 months prior to study entry:
CL Item
Systemic corticosteroids for asthma (1)
CL Item
Asthma­-specific hospital admissions (2)
CL Item
Asthma­-specific ED visits (separate UC visits when these can be differentiated) (3)
Item
History of:
text
C0042153 (UMLS CUI [1,1])
C0086388 (UMLS CUI [1,2])
C0010186 (UMLS CUI [2,1])
C0086388 (UMLS CUI [2,2])
Utilization healthcare; Costs healthcare
Code List
History of:
CL Item
Asthma-­specific hospital admissions  (1)
CL Item
Asthma­-specific ED visits  (2)
CL Item
Asthma-­specific outpatient visits  (3)
CL Item
Asthma-­specific detailed medication use (name, dose, duration) (4)
CL Item
Resource use related to the intervention (eg, personnel time, mite eradication, equipment) (5)
medication asthma
Item
If option 4 chosen above, please mention the name, dose and duration of the asthma medication used
text
C0013227 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
Physiology Pulmonary
Item
Spirometry (pre­ and post­ bronchodilator)
text
C0031842 (UMLS CUI [1,1])
C0024109 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial